Prostate Cancer Screening and Determining the Appropriate Prostate-Specific Antigen Cutoff Values

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.8, Iss.2, 2010-02, pp. : 265-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate-specific antigen

By Ornstein D.K. Pruthi R.S.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. : 1399-1411

Informa Healthcare

Access to resources Recommend Favorite

PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-01 ,pp. : 951-962

Bentham Science Publishers

Access to resources Recommend Favorite

Expected population impacts of discontinued prostate-specific antigen screening

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3519-3526

Blackwell Publishing

Access to resources Recommend Favorite

Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer

By Mahal Brandon A. Aizer Ayal A. Efstathiou Jason A. Nguyen Paul L.

Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. : 78-83

Blackwell Publishing

Access to resources Recommend Favorite

Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen

By Slovin Susan F

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 561-570

Informa Healthcare

Access to resources Recommend Favorite